ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking

July 18, 2014

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

Cancer Atlast Offers New Research Leads

July 17, 1987

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992